Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-10-13

Clinical Trial Update: Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous Blood [Phase 3]

View source ↗

Summary

A Phase 3 trial update describing fingerprick autologous blood as a treatment for dry eyes and corneal ulcers, with current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingerprick autologous blood

Snippet

Sponsor: Bedford Hospital NHS Trust | Conditions: Dry Eyes, Sjogren's Disease With Dry Eyes | Phase 3 | Status: UNKNOWN